{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:24:07Z","timestamp":1790623447491,"version":"4.1.0"},"reference-count":125,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s273503","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T03:35:18Z","timestamp":1671161718000},"page":"2927-2943","source":"Crossref","is-referenced-by-count":62,"title":["Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Omar H","family":"Elsayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mete","family":"Ercis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehak","family":"Pahwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-8192","authenticated-orcid":true,"given":"Balwinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","volume":"37","author":"Clemente","year":"2015","journal-title":"Braz J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/bdi.13208","volume":"24","author":"Burdick","year":"2022","journal-title":"Bipolar Disord"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.4088\/JCP.v67n0806","volume":"67","author":"Gardner","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.4088\/JCP.v67n1009","volume":"67","author":"Altshuler","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","volume":"9","author":"Kupka","year":"2007","journal-title":"Bipolar Disord"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/YIC.0b013e32833c4ceb","volume":"25","author":"Mendlewicz","year":"2010","journal-title":"Int Clin Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord"},{"key":"ref8","first-page":"45","volume":"52","author":"Park","year":"2022","journal-title":"Psychopharmacol Bull"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0193-953X(05)70285-9","volume":"19","author":"Sachs","year":"1996","journal-title":"Psychiatr Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1034\/j.1399-5618.2003.00019.x","volume":"5","author":"Yatham","year":"2003","journal-title":"Bipolar Disord"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1176\/appi.ajp.163.2.210","volume":"163","author":"Nierenberg","year":"2006","journal-title":"Am J Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.mp.4001793","volume":"11","author":"Gitlin","year":"2006","journal-title":"Mol Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1517\/14656560903064170","volume":"10","author":"Gajwani","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1600-0447.2009.01471.x","volume":"120","author":"Pacchiarotti","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1399-5618.2010.00868.x","volume":"12","author":"Lipsman","year":"2010","journal-title":"Bipolar Disord"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1399-5618.2012.00993.x","volume":"14","author":"Malhi","year":"2012","journal-title":"Bipolar Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1399-5618.2012.01042.x","volume":"14","author":"Poon","year":"2012","journal-title":"Bipolar Disord"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1192\/bjp.2018.257","volume":"214","author":"Hidalgo-Mazzei","year":"2019","journal-title":"Br J Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/ijnp\/pyz064","volume":"23","author":"Fountoulakis","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref20","unstructured":"American Psychiatric Association. Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision). American Psychiatric Pub; 2002."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/15622970903555881","volume":"11","author":"Grunze","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"ref22","unstructured":"National Institute for Health and Care Excellence (NICE). National institute for health and care excellence: guidelines. In: Bipolar Disorder: Assessment and Management. London: National Institute for Health and Care Excellence (NICE) Copyright \u00a9 NICE 2019; 2018."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/0269881116636545","volume":"30","author":"Goodwin","year":"2016","journal-title":"J Psychopharmacol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0004867420979353","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust N Z J Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4088\/JCP.08m04152","volume":"70","author":"van der Loos","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","volume":"20","author":"Frye","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1600-0447.2009.01537.x","volume":"122","author":"van der Loos","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1600-0447.1993.tb03487.x","volume":"88","author":"Bocchetta","year":"1993","journal-title":"Acta Psychiatr Scand"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","volume":"171","author":"Loebel","year":"2014","journal-title":"Am J Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1176\/appi.ajp.158.6.906","volume":"158","author":"Nemeroff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4088\/JCP.09m05934","volume":"72","author":"Sachs","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1176\/appi.ajp.161.3.564","volume":"161","author":"Goldberg","year":"2004","journal-title":"Am J Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/JCP.0000000000000222","volume":"34","author":"Murphy","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bdi.12859","volume":"22","author":"Nunez","year":"2020","journal-title":"Bipolar Disord"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","volume":"164","author":"Frye","year":"2007","journal-title":"Am J Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.4088\/JCP.09m05900gry","volume":"71","author":"Calabrese","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.4088\/JCP.13m08951","volume":"75","author":"Calabrese","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jad.2015.04.012","volume":"181","author":"Ketter","year":"2015","journal-title":"J Affect Disord"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jad.2019.10.021","volume":"261","author":"Halaris","year":"2020","journal-title":"J Affect Disord"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4088\/JCP.21m14022","volume":"83","author":"Calkin","year":"2022","journal-title":"J Clin Psychiatry"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/da.22340","volume":"32","author":"Zeinoddini","year":"2015","journal-title":"Depress Anxiety"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jad.2018.11.090","volume":"245","author":"Aftab","year":"2019","journal-title":"J Affect Disord"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pbb.2018.12.006","volume":"177","author":"Fries","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/acps.13016","volume":"139","author":"Kohler-Forsberg","year":"2019","journal-title":"Acta Psychiatr Scand"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"112781","DOI":"10.1016\/j.psychres.2020.112781","volume":"284","author":"Castillo","year":"2020","journal-title":"Psychiatry Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2018.02.004","volume":"102","author":"Edberg","year":"2018","journal-title":"J Psychiatr Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jpsychires.2020.06.010","volume":"129","author":"Edberg","year":"2020","journal-title":"J Psychiatr Res"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","volume":"206","author":"Calkin","year":"2015","journal-title":"Br J Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.22ac14590","volume":"83","author":"Singh","year":"2022","journal-title":"J Clin Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jad.2008.12.010","volume":"116","author":"Kelly","year":"2009","journal-title":"J Affect Disord"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1097\/00001756-200109170-00043","volume":"12","author":"Law","year":"2001","journal-title":"Neuroreport"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2006.09.011","volume":"1127","author":"McCullumsmith","year":"2007","journal-title":"Brain Res"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/archpsyc.61.7.649","volume":"61","author":"Woo","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/npp.2009.191","volume":"35","author":"Brennan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.biopsych.2004.11.023","volume":"57","author":"Zarate","year":"2005","journal-title":"Biol Psychiatry"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/aps.2016.5","volume":"37","author":"Gao","year":"2016","journal-title":"Acta Pharmacol Sin"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/JCP.0000000000001317","volume":"41","author":"Joseph","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1080\/14740338.2022.2045272","volume":"21","author":"Singh","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","volume":"175","author":"Canuso","year":"2018","journal-title":"Am J Psychiatry"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"858251","DOI":"10.1155\/2015\/858251","volume":"2015","author":"Xu","year":"2015","journal-title":"Neural Plast"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1038\/tp.2014.105","volume":"4","author":"Lally","year":"2014","journal-title":"Transl Psychiatry"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jad.2016.01.009","volume":"194","author":"Saligan","year":"2016","journal-title":"J Affect Disord"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1111\/bph.12494","volume":"171","author":"Villasenor","year":"2014","journal-title":"Br J Pharmacol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e10208","DOI":"10.7717\/peerj.10208","volume":"8","author":"Zheng","year":"2020","journal-title":"PeerJ"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/bdi.13129","volume":"23","author":"Singh","year":"2021","journal-title":"Bipolar Disord"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbi.2020.01.004","volume":"87","author":"Murata","year":"2020","journal-title":"Brain Behav Immun"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.2147\/NDT.S325000","volume":"17","author":"Wilkowska","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1176\/appi.ajp.2014.13111517","volume":"172","author":"Schoeyen","year":"2015","journal-title":"Am J Psychiatry"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"e1306","DOI":"10.4088\/JCP.13m08960","volume":"75","author":"Kessler","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/bdi.12594","volume":"20","author":"Bjoerke-Bertheussen","year":"2018","journal-title":"Bipolar Disord"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1399-5618.2009.00702.x","volume":"11","author":"Sienaert","year":"2009","journal-title":"Bipolar Disord"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1600-0447.2009.01493.x","volume":"121","author":"Bailine","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jad.2016.03.052","volume":"198","author":"Fitzgerald","year":"2016","journal-title":"J Affect Disord"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1038\/npp.2017.26","volume":"42","author":"Tavares","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/npr2.12066","volume":"39","author":"Kito","year":"2019","journal-title":"Neuropsychopharmacol Rep"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.brs.2021.07.018","volume":"14","author":"Chen","year":"2021","journal-title":"Brain Stimul"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.biopsych.2005.05.025","volume":"58","author":"Rush","year":"2005","journal-title":"Biol Psychiatry"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.biopsych.2008.04.036","volume":"64","author":"Nierenberg","year":"2008","journal-title":"Biol Psychiatry"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40345-020-0178-4","volume":"8","author":"McAllister-Williams","year":"2020","journal-title":"Int J Bipolar Disord"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/archgenpsychiatry.2011.1456","volume":"69","author":"Holtzheimer","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"ref85","unstructured":"Intra-Cellular Therapies I. Clinical trial evaluating lumateperone monotherapy in the treatment of bipolar depression or major depressive disorder; 2020. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04285515. Accessed December 8, 2022."},{"key":"ref86","unstructured":"University FAHoZ, University Z. Vortioxetine adjunctive treatment in bipolar depression; 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05481957. Accessed December 8, 2022."},{"key":"ref87","unstructured":"Clinic M, Hope L. 8 week multi-site study of MYDAYIS\u00ae for bipolar depression; 2020. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04235686. Accessed December 8, 2022."},{"key":"ref88","unstructured":"Institute DMHU, University M, Hospital JG. Brexpiprazole treatment for bipolar I depression; 2021. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04569448. Accessed December 8, 2022."},{"key":"ref89","unstructured":"University Health Network T. Maintenance ketamine infusions for treatment-resistant bipolar depression; 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05339074. Accessed December 8, 2022."},{"key":"ref90","unstructured":"Center SMH. Efficacy and safety of peropirone hydrochloride tablets in the treatment of adolescent bipolar disorder depression; 2020. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04826510. Accessed December 8, 2022."},{"key":"ref91","unstructured":"Clinic M. Ketamine associated ACC GABA and glutamate change and depression remission; 2019. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03573349. Accessed December 8, 2022."},{"key":"ref92","unstructured":"Consorcio Centro de Investigaci\u00f3n Biom\u00e9dica en Red MP, Institute SMR. Trehalose as add-on therapy in bipolar depression; 2016. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT02800161. Accessed December 8, 2022."},{"key":"ref93","unstructured":"Fe IdISL, Medicines SAo, Products H, Fe HUL. Efficacy of TBS in treatment resistant depression; 2021. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04998773. Accessed December 8, 2022."},{"key":"ref94","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brs.2019.08.013","volume":"13","author":"Fitzgerald","year":"2020","journal-title":"Brain Stimul"},{"key":"ref95","unstructured":"Hallahan DB, Institute SMR, National University of Ireland G, Ireland, HRB Clinical Research Facility Galway I, Galway UCH. Scopolamine in bipolar depression; 2021. Available form: https:\/\/ClinicalTrials.gov\/show\/NCT04211961. Accessed December 8, 2022."},{"key":"ref96","unstructured":"Health NIoM, Center NIoHC. Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD; 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05172271. Accessed December 8, 2022."},{"key":"ref97","unstructured":"Hospital MG. Xenon inhalation therapy for major depressive disorder and bipolar disorder; 2019. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03748446. Accessed December 8, 2022."},{"key":"ref98","unstructured":"Hospital MG, Brain, Foundation BR, Willard J, Foundation ASM. BezafibrateTreatment for Bipolar Depression: a Proof of Concept Study; 2015. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT02481245. Accessed December 8, 2022."},{"key":"ref99","unstructured":"Janssen Pharmaceutica N.V. B. A Study of JNJ-55308942 in the treatment of bipolar depression; 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05328297. Accessed December 8, 2022."},{"key":"ref100","unstructured":"Kong CUoH. Adjunctive bright light therapy in patients with bipolar depression and eveningness; 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05357313. Accessed December 8, 2022."},{"key":"ref101","unstructured":"Korea Otsuka Pharmaceutical Co. A study of abilify\u00ae tablet (aripiprazole) as an adjunctive treatment in the bipolar depression; 2018. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03423680. Accessed December 8, 2022."},{"key":"ref102","unstructured":"NeuroRx I, Prevail Infoworks I. NRX101 for bipolar depression and sub-acute suicidal ideation and behavior; 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03395392. Accessed December 8, 2022."},{"key":"ref103","unstructured":"Paris AP-Hd, Pharma I. Low dose IL-2 therapy in patients with a depressive episode in the course of a bipolar disorder; 2020. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04133233. Accessed December 8, 2022."},{"key":"ref104","unstructured":"Paulo UoS. Creatine monohydrate as adjuvant therapy for bipolar depression; 2012. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT01655030. Accessed December 8, 2022."},{"key":"ref105","unstructured":"Paulo UoS, Paulo FdA\u00e0PdEdS. Electro-magnetic convulsive therapies for depression: a non-inferiority study; 2021. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05054699. Accessed December 8, 2022."},{"key":"ref106","unstructured":"Pennsylvania Uo. Intensive TMS for bipolar depression; 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05228457. Accessed December 8, 2022."},{"key":"ref107","unstructured":"Sunovion. A clinical study of an investigational drug for the treatment of major depressive episode associated with bipolar I disorder; 2021. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05169710. Accessed December 8, 2022."},{"key":"ref108","unstructured":"Taylor V, University Health Network T, Hospital WsC. Safety and efficacy of fecal microbiota transplantation in a population with bipolar disorder; 2018. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03279224. Accessed December 8, 2022."},{"key":"ref109","unstructured":"The University of Texas Health Science Center H. Adjunctive allogeneic mesenchymal stem cells for treatment-resistant bipolar depression; 2021. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03522545. Accessed December 8, 2022."},{"key":"ref110","unstructured":"University G, AB ACR. OSU6162 in bipolar depression (OBID); 2021. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05296356. Accessed December 8, 2022."},{"key":"ref111","unstructured":"University JH, Fund BBR, Medical M, Austin UoTa. iTBS in bipolar I depression; 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05375214. Accessed December 8, 2022."},{"key":"ref112","unstructured":"University of California SF. Psilocybin therapy for depression in bipolar II disorder; 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05065294. Accessed December 8, 2022."},{"key":"ref113","unstructured":"University Qs, Clinic OP. Delivering electronic cognitive behavioural therapy to patients with bipolar disorder and residual depressive symptoms; 2020. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04664257. Accessed December 8, 2022."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jad.2019.02.056","volume":"249","author":"Brown","year":"2019","journal-title":"J Affect Disord"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1176\/appi.ajp.2021.20091339","volume":"178","author":"Calabrese","year":"2021","journal-title":"Am J Psychiatry"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s40265-016-0655-3","volume":"76","author":"Frampton","year":"2016","journal-title":"Drugs"},{"key":"ref117","unstructured":"Gdansk MUo. A naturalistic study of ketamine for treatment resistant mood disorders; 2019. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04226963. Accessed December 8, 2022."},{"key":"ref118","unstructured":"System SPH, Pathways C. The safety and efficacy of psilocybin in participants with type 2 bipolar disorder (BP-II) depression; 2021. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04433845. Accessed December 8, 2022."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"48674221083868","DOI":"10.1177\/00048674221083868","author":"Kisely","year":"2022","journal-title":"Aust N Z J Psychiatry"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/bdi.13095","volume":"23","author":"Hendin","year":"2021","journal-title":"Bipolar Disord"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am J Psychiatry"},{"key":"ref123","unstructured":"The University of Texas Health Science Center H. Magnetic seizure therapy in bipolar depression (MST-BpD); 2022. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04080778. Accessed December 8, 2022."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40345-022-00265-5","volume":"10","author":"Bosch","year":"2022","journal-title":"Int J Bipolar Disord"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/brainsci12111540","volume":"12","author":"Seshadri","year":"2022","journal-title":"Brain Sci"}],"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=86223","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=86223","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T03:35:47Z","timestamp":1671161747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/treatment-resistant-bipolar-depression-therapeutic-trends-challenges-a-peer-reviewed-fulltext-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":125,"URL":"https:\/\/doi.org\/10.2147\/ndt.s273503","relation":{},"ISSN":["1178-2021"],"issn-type":[{"value":"1178-2021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}